| 1 | ONCIPC8C ;Hines OIFO/GWB - Primary Intracranial/CNS Tumors PCE Study ;05/01/00
 | 
|---|
| 2 |  ;;2.11;ONCOLOGY;**26,32**;Mar 07, 1995
 | 
|---|
| 3 |  ;Print (continued)
 | 
|---|
| 4 |  W !?4,"CHEMOTHERAPY",!?4,"------------"
 | 
|---|
| 5 |  D P Q:EX=U
 | 
|---|
| 6 |  W !,"61. DATE CHEMOTHERAPY STARTED.....: ",$$GET1^DIQ(165.5,IE,53)
 | 
|---|
| 7 |  D P Q:EX=U
 | 
|---|
| 8 |  W !,"62. CHEMOTHERAPY..................: ",$$GET1^DIQ(165.5,IE,53.2)
 | 
|---|
| 9 |  D P Q:EX=U
 | 
|---|
| 10 |  W !
 | 
|---|
| 11 |  D P Q:EX=U
 | 
|---|
| 12 |  W !,"63. TYPE OF CHEMOTHERAPEUTIC AGENTS ADMINISTERED:"
 | 
|---|
| 13 |  D P Q:EX=U
 | 
|---|
| 14 |  W !,"     PROCARBAZINE.................: ",$$GET1^DIQ(165.5,IE,1346)
 | 
|---|
| 15 |  D P Q:EX=U
 | 
|---|
| 16 |  W !,"     CCNU.........................: ",$$GET1^DIQ(165.5,IE,1347)
 | 
|---|
| 17 |  D P Q:EX=U
 | 
|---|
| 18 |  W !,"     VINCRISTINE..................: ",$$GET1^DIQ(165.5,IE,1348)
 | 
|---|
| 19 |  D P Q:EX=U
 | 
|---|
| 20 |  W !,"     HYDROXYUREA..................: ",$$GET1^DIQ(165.5,IE,1349)
 | 
|---|
| 21 |  D P Q:EX=U
 | 
|---|
| 22 |  W !,"     METHOTREXATE.................: ",$$GET1^DIQ(165.5,IE,376)
 | 
|---|
| 23 |  D P Q:EX=U
 | 
|---|
| 24 |  W !,"     CISPLATIN....................: ",$$GET1^DIQ(165.5,IE,371)
 | 
|---|
| 25 |  D P Q:EX=U
 | 
|---|
| 26 |  W !,"     BCNU.........................: ",$$GET1^DIQ(165.5,IE,1350)
 | 
|---|
| 27 |  D P Q:EX=U
 | 
|---|
| 28 |  W !,"     BCNU, WAFER IMPLANT..........: ",$$GET1^DIQ(165.5,IE,1351)
 | 
|---|
| 29 |  D P Q:EX=U
 | 
|---|
| 30 |  W !,"     VP-16........................: ",$$GET1^DIQ(165.5,IE,1352)
 | 
|---|
| 31 |  D P Q:EX=U
 | 
|---|
| 32 |  W !,"     CARBOPLATIN..................: ",$$GET1^DIQ(165.5,IE,1353)
 | 
|---|
| 33 |  D P Q:EX=U
 | 
|---|
| 34 |  W !,"     TEMOZOLOMIDE.................: ",$$GET1^DIQ(165.5,IE,1354)
 | 
|---|
| 35 |  D P Q:EX=U
 | 
|---|
| 36 |  W !,"     CYCLOPHOSPHAMIDE.............: ",$$GET1^DIQ(165.5,IE,372)
 | 
|---|
| 37 |  D P Q:EX=U
 | 
|---|
| 38 |  W !,"     CPT-11.......................: ",$$GET1^DIQ(165.5,IE,1355)
 | 
|---|
| 39 |  D P Q:EX=U
 | 
|---|
| 40 |  W !,"     TAMOXIFEN....................: ",$$GET1^DIQ(165.5,IE,1356)
 | 
|---|
| 41 |  D P Q:EX=U
 | 
|---|
| 42 |  W !,"     INTERFERON...................: ",$$GET1^DIQ(165.5,IE,384)
 | 
|---|
| 43 |  D P Q:EX=U
 | 
|---|
| 44 |  W !,"     CYTARABINE (ARA-C)...........: ",$$GET1^DIQ(165.5,IE,1357)
 | 
|---|
| 45 |  D P Q:EX=U
 | 
|---|
| 46 |  W !,"     OTHER........................: ",$$GET1^DIQ(165.5,IE,380)
 | 
|---|
| 47 |  D P Q:EX=U
 | 
|---|
| 48 |  W !
 | 
|---|
| 49 |  D P Q:EX=U
 | 
|---|
| 50 |  W !,"64. CHEMOTHERAPEUTIC ROUTE........: ",$$GET1^DIQ(165.5,IE,1358)
 | 
|---|
| 51 |  D P Q:EX=U
 | 
|---|
| 52 |  W !
 | 
|---|
| 53 |  D P Q:EX=U
 | 
|---|
| 54 |  W !,"65. CHEMOTHERAPY COMPLICATIONS:"
 | 
|---|
| 55 |  D P Q:EX=U
 | 
|---|
| 56 |  W !,"     HEARING LOSS.................: ",$$GET1^DIQ(165.5,IE,1359)
 | 
|---|
| 57 |  D P Q:EX=U
 | 
|---|
| 58 |  W !,"     INFECTION....................: ",$$GET1^DIQ(165.5,IE,1360)
 | 
|---|
| 59 |  D P Q:EX=U
 | 
|---|
| 60 |  W !,"     NAUSEA AND VOMITING REQUIRING"
 | 
|---|
| 61 |  D P Q:EX=U
 | 
|---|
| 62 |  W !,"      CESSATION OF CHEMOTHERAPY...: ",$$GET1^DIQ(165.5,IE,1361)
 | 
|---|
| 63 |  D P Q:EX=U
 | 
|---|
| 64 |  W !,"     PERIPHERAL BLOOD COUNT DROP/"
 | 
|---|
| 65 |  D P Q:EX=U
 | 
|---|
| 66 |  W !,"      /BLEEDING/CESSATION OF CHEMO"
 | 
|---|
| 67 |  D P Q:EX=U
 | 
|---|
| 68 |  W !,"      AND/OR TRANSFUSION..........: ",$$GET1^DIQ(165.5,IE,1362)
 | 
|---|
| 69 |  D P Q:EX=U
 | 
|---|
| 70 |  W !,"     PERIPHERAL NEUROPATHY........: ",$$GET1^DIQ(165.5,IE,1363)
 | 
|---|
| 71 |  D P Q:EX=U
 | 
|---|
| 72 |  W !,"     RENAL FAILURE................: ",$$GET1^DIQ(165.5,IE,1364)
 | 
|---|
| 73 |  D P Q:EX=U
 | 
|---|
| 74 |  W !,"     PULMONARY TOXICITY...........: ",$$GET1^DIQ(165.5,IE,1365)
 | 
|---|
| 75 |  D P Q:EX=U
 | 
|---|
| 76 |  W !,"     OTHER........................: ",$$GET1^DIQ(165.5,IE,1366)
 | 
|---|
| 77 |  D P Q:EX=U
 | 
|---|
| 78 |  W !
 | 
|---|
| 79 |  D P Q:EX=U
 | 
|---|
| 80 |  W !,"66. REASON FOR NO CHEMOTHERAPY....: ",$$GET1^DIQ(165.5,IE,76)
 | 
|---|
| 81 |  D P Q:EX=U
 | 
|---|
| 82 |  I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y  D HEAD^ONCIPC0 G OT
 | 
|---|
| 83 |  W !
 | 
|---|
| 84 |  D P Q:EX=U
 | 
|---|
| 85 | OT W !?4,"OTHER THERAPY",!?4,"-------------"
 | 
|---|
| 86 |  D P Q:EX=U
 | 
|---|
| 87 |  W !,"67. DATE OTHER TREATMENT STARTED..: ",$$GET1^DIQ(165.5,IE,57)
 | 
|---|
| 88 |  D P Q:EX=U
 | 
|---|
| 89 |  W !,"68. OTHER TREATMENT...............: ",$$GET1^DIQ(165.5,IE,57.2)
 | 
|---|
| 90 |  D P Q:EX=U
 | 
|---|
| 91 |  W !,"69. KARNOFSKY'S RATING AT TIME OF"
 | 
|---|
| 92 |  D P Q:EX=U
 | 
|---|
| 93 |  W !,"     DISCHARGE/TRANSFER...........: ",$$GET1^DIQ(165.5,IE,1367)
 | 
|---|
| 94 |  D P Q:EX=U
 | 
|---|
| 95 |  I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y  D HEAD^ONCIPC0 G IV
 | 
|---|
| 96 |  D P Q:EX=U
 | 
|---|
| 97 | IV S TABLE="RECURRENCE/PROGRESSION"
 | 
|---|
| 98 |  I IOST'?1"C".E W !
 | 
|---|
| 99 |  W !?4,TABLE,!?4,"----------------------"
 | 
|---|
| 100 |  D P Q:EX=U
 | 
|---|
| 101 |  W !,"70. DATE OF FIRST RECURRENCE......: ",$$GET1^DIQ(165.5,IE,70)
 | 
|---|
| 102 |  D P Q:EX=U
 | 
|---|
| 103 |  W !,"71. TYPE OF FIRST RECURRENCE......: ",$$GET1^DIQ(165.5,IE,1372)
 | 
|---|
| 104 |  D P Q:EX=U
 | 
|---|
| 105 |  W !,"72. DATE OF PROGRESSION...........: ",$$GET1^DIQ(165.5,IE,1368)
 | 
|---|
| 106 |  D P Q:EX=U
 | 
|---|
| 107 |  W !,"73. TYPE OF PROGRESSION...........: ",$$GET1^DIQ(165.5,IE,1369)
 | 
|---|
| 108 |  D P Q:EX=U
 | 
|---|
| 109 |  W !,"74. RECURRENCE/PROGRESSION"
 | 
|---|
| 110 |  D P Q:EX=U
 | 
|---|
| 111 |  W !,"     DOCUMENTATION................: ",$$GET1^DIQ(165.5,IE,1370)
 | 
|---|
| 112 |  D P Q:EX=U
 | 
|---|
| 113 |  W !,"75. KARNOFSKY'S RATING AT TIME OF"
 | 
|---|
| 114 |  D P Q:EX=U
 | 
|---|
| 115 |  W !,"     RECURRENCE/PROGRESSION.......: ",$$GET1^DIQ(165.5,IE,1371)
 | 
|---|
| 116 |  D P Q:EX=U
 | 
|---|
| 117 |  I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y  D HEAD^ONCIPC0 G V
 | 
|---|
| 118 |  W !
 | 
|---|
| 119 |  D P Q:EX=U
 | 
|---|
| 120 | V S TABLE="SUBSEQUENT TREATMENT"
 | 
|---|
| 121 |  W !?4,TABLE,!?4,"--------------------"
 | 
|---|
| 122 |  D P Q:EX=U
 | 
|---|
| 123 |  S DSTRP=""
 | 
|---|
| 124 |  I $D(^ONCO(165.5,IE,4,0)) D
 | 
|---|
| 125 |  .S SCTIEN=$O(^ONCO(165.5,IE,4,0))
 | 
|---|
| 126 |  .Q:SCTIEN=""
 | 
|---|
| 127 |  .S DSTRP=$P(^ONCO(165.5,ONCONUM,4,SCTIEN,0),U,1)
 | 
|---|
| 128 |  .S Y=DSTRP D DATEOT^ONCOPCE S DSTRP=Y
 | 
|---|
| 129 |  W !,"76. DATE OF SUBSEQUENT TREATMENT"
 | 
|---|
| 130 |  D P Q:EX=U
 | 
|---|
| 131 |  W !,"     FOR RECURRENCE/PROGRESSION...: ",DSTRP
 | 
|---|
| 132 |  D P Q:EX=U
 | 
|---|
| 133 |  W !,"77. PROTOCOL PARTCIPATION"
 | 
|---|
| 134 |  D P Q:EX=U
 | 
|---|
| 135 |  W !,"     (SUBSEQUENT TREATMENT).......: ",$$GET1^DIQ(165.5,IE,1373)
 | 
|---|
| 136 |  D P Q:EX=U
 | 
|---|
| 137 |  W !,"78. TYPE OF SUBSEQUENT SURGICAL TX"
 | 
|---|
| 138 |  D P Q:EX=U
 | 
|---|
| 139 |  W !,"     FOR RECURRENCE/PROGRESSION...: ",$$GET1^DIQ(165.5,IE,1374)
 | 
|---|
| 140 |  D P Q:EX=U
 | 
|---|
| 141 |  W !,"79. TYPE OF SUBSEQUENT RADIATION"
 | 
|---|
| 142 |  D P Q:EX=U
 | 
|---|
| 143 |  W !,"     TX FOR RECURRENCE/PROGRESSION: ",$$GET1^DIQ(165.5,IE,1375)
 | 
|---|
| 144 |  D P Q:EX=U
 | 
|---|
| 145 |  W !
 | 
|---|
| 146 |  D P Q:EX=U
 | 
|---|
| 147 |  W !,"80. TYPE OF SUBSEQUENT CHEMOTHERAPY FOR RECURRENCE/PROGRESSION:"
 | 
|---|
| 148 |  D P Q:EX=U
 | 
|---|
| 149 |  W !,"     PROCARBAZINE.................: ",$$GET1^DIQ(165.5,IE,1376)
 | 
|---|
| 150 |  D P Q:EX=U
 | 
|---|
| 151 |  W !,"     CCNU.........................: ",$$GET1^DIQ(165.5,IE,1377)
 | 
|---|
| 152 |  D P Q:EX=U
 | 
|---|
| 153 |  W !,"     VINCRISTINE..................: ",$$GET1^DIQ(165.5,IE,1378)
 | 
|---|
| 154 |  D P Q:EX=U
 | 
|---|
| 155 |  W !,"     HYDROXYUREA..................: ",$$GET1^DIQ(165.5,IE,1379)
 | 
|---|
| 156 |  D P Q:EX=U
 | 
|---|
| 157 |  W !,"     METHOTREXATE.................: ",$$GET1^DIQ(165.5,IE,1380)
 | 
|---|
| 158 |  D P Q:EX=U
 | 
|---|
| 159 |  W !,"     CISPLATIN....................: ",$$GET1^DIQ(165.5,IE,1381)
 | 
|---|
| 160 |  D P Q:EX=U
 | 
|---|
| 161 |  W !,"     BCNU.........................: ",$$GET1^DIQ(165.5,IE,1382)
 | 
|---|
| 162 |  D P Q:EX=U
 | 
|---|
| 163 |  W !,"     BCNU, WAFER IMPLANT..........: ",$$GET1^DIQ(165.5,IE,1383)
 | 
|---|
| 164 |  D P Q:EX=U
 | 
|---|
| 165 |  W !,"     VP-16........................: ",$$GET1^DIQ(165.5,IE,1384)
 | 
|---|
| 166 |  D P Q:EX=U
 | 
|---|
| 167 |  W !,"     CARBOPLATIN..................: ",$$GET1^DIQ(165.5,IE,1385)
 | 
|---|
| 168 |  D P Q:EX=U
 | 
|---|
| 169 |  W !,"     TEMOZOLOMIDE.................: ",$$GET1^DIQ(165.5,IE,1386)
 | 
|---|
| 170 |  D P Q:EX=U
 | 
|---|
| 171 |  W !,"     CYCLOPHOSPHAMIDE.............: ",$$GET1^DIQ(165.5,IE,1387)
 | 
|---|
| 172 |  D P Q:EX=U
 | 
|---|
| 173 |  W !,"     CPT-11.......................: ",$$GET1^DIQ(165.5,IE,1388)
 | 
|---|
| 174 |  D P Q:EX=U
 | 
|---|
| 175 |  W !,"     TAMOXIFEN....................: ",$$GET1^DIQ(165.5,IE,1389)
 | 
|---|
| 176 |  D P Q:EX=U
 | 
|---|
| 177 |  W !,"     INTERFERON...................: ",$$GET1^DIQ(165.5,IE,1390)
 | 
|---|
| 178 |  D P Q:EX=U
 | 
|---|
| 179 |  W !,"     CYTARABINE (ARA-C)...........: ",$$GET1^DIQ(165.5,IE,1391)
 | 
|---|
| 180 |  D P Q:EX=U
 | 
|---|
| 181 |  W !,"     OTHER........................: ",$$GET1^DIQ(165.5,IE,1392)
 | 
|---|
| 182 |  D P Q:EX=U
 | 
|---|
| 183 |  W !
 | 
|---|
| 184 |  D P Q:EX=U
 | 
|---|
| 185 |  W !,"81. OTHER TYPE OF SUBSEQUENT TX"
 | 
|---|
| 186 |  D P Q:EX=U
 | 
|---|
| 187 |  W !,"     FOR RECURRENCE/PROGRESSION...: ",$$GET1^DIQ(165.5,IE,1393)
 | 
|---|
| 188 |  I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR Q:'Y  D HEAD^ONCIPC0 G VI
 | 
|---|
| 189 |  W !
 | 
|---|
| 190 |  D P Q:EX=U
 | 
|---|
| 191 | VI S TABLE="STATUS AT LAST CONTACT"
 | 
|---|
| 192 |  W !?4,TABLE,!?4,"----------------------"
 | 
|---|
| 193 |  D P Q:EX=U
 | 
|---|
| 194 |  S DLC="" I $D(^ONCO(160,ONCOPA,"F","B")) S DLC=$O(^ONCO(160,ONCOPA,"F","B",""),-1)
 | 
|---|
| 195 |  I DLC'="" S Y=DLC D DATEOT^ONCOPCE S DLC=Y
 | 
|---|
| 196 |  W !,"82. DATE OF LAST CONTACT OR DEATH.: ",DLC
 | 
|---|
| 197 |  D P Q:EX=U
 | 
|---|
| 198 |  W !,"83. VITAL STATUS..................: ",$$GET1^DIQ(160,ONCOPA,15)
 | 
|---|
| 199 |  D P Q:EX=U
 | 
|---|
| 200 |  S CS="" I $D(^ONCO(165.5,IE,"TS","AA")) D
 | 
|---|
| 201 |  .S CSDAT=$O(^ONCO(165.5,IE,"TS","AA",""))
 | 
|---|
| 202 |  .S CSI=$O(^ONCO(165.5,IE,"TS","AA",CSDAT,""))
 | 
|---|
| 203 |  .S CSPNT=$P(^ONCO(165.5,IE,"TS",CSI,0),U,2)
 | 
|---|
| 204 |  .S CS=$P(^ONCO(164.42,CSPNT,0),U,1)
 | 
|---|
| 205 |  W !,"84. CANCER STATUS.................: ",CS
 | 
|---|
| 206 |  I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR
 | 
|---|
| 207 |  Q
 | 
|---|
| 208 | P ;Print
 | 
|---|
| 209 |  I ($Y'<(LIN-1)) D  Q:EX=U
 | 
|---|
| 210 |  .I IOST?1"C".E W ! K DIR S DIR(0)="E" D ^DIR I 'Y S EX=U Q
 | 
|---|
| 211 |  .D HEAD^ONCIPC0 Q
 | 
|---|
| 212 |  Q
 | 
|---|